Chronic kidney disease (CKD) is one of the most common diabetes-related complications, affecting close to 40% of people living with diabetes. Furthermore, people with CKD are at greater risk of developing cardiovascular disease (CVD), a second high-risk diabetes-related complication. With the prevalence of diabetes on the rise globally, it is crucial to address the link between diabetes and kidney disease to find strategies to reduce its impact.
In 2023, the IDF Diabetes Atlas reported that approximately 30 to 40% of people living with diabetes develop CKD. In addition, CKD due to type 2 diabetes increased worldwide by about 74% between 1990 and 2017.
During this online event, expert speakers and panellists shared their insights on various aspects of diabetes-related kidney disease, and highlighted the significance of data collection and analysis in improving clinical care for people with diabetes-related kidney disease.
Topics included:
- Early detection and prevention strategies.
- Innovative treatment options.
- The importance of multidisciplinary care for people with diabetes and kidney disease.
Panellist included:
- Prof Akhtar Hussain, IDF President (Bangladesh/Norway)
- Prof Edward J Boyko, Professor University of Washington and IDF Diabetes Atlas co-chair (USA)
- Prof Carol Pollock, Professor University of Sydney (Australia)
- Mishary Alassiri, IDF Young Leaders in Diabetes member (Saudi Arabia)
- Valérie Luyckx, ISN Advocacy Working Group (Switzerland)
- Michael Donohoe, IDF Blue Circle Voices member (USA)
Watch the recording below:
